We looked at the relationship between patient survival probability and expression levels of EphrinB2 and its receptors in colorectal tumors (E‐GEOD‐17538: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317538). Here, EFNB2 is linked to colorectal neoplasm.